A multicenter prospective comparative study was recently published in Therapeutic Advances in Neurological Disorders. The publication characterizes the efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy, with or without diabetes.
This study was authored by Samir P. Macwan, Shalini Mahajan, Peter Novak, Khosro Farhad, Ericka Wong, Thomas H. Brannagan, Sohail Masood, Fawad Piracha and Marinos C. Dalakas.
View the article here: https://doi.org/10.1177/17562864251401496